Insulin resistance and cardiovascular disease

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience.

Diabetologia·2012

Diabetes and dyslipidemia.

Heart failure monitor·2003

HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia.

Nature medicine·2001

Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance.

Diabetes, obesity & metabolism·2001

Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance.

The Journal of biological chemistry·2001

Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus.

The American journal of cardiology·2001

Tumor NLRP3 Amplification Promotes Immunotherapy Resistance by Inhibiting STAT1 Signaling and MHC Class I Expression.

The Journal of clinical investigation·2026

Insulin resistance is associated with mammary mitochondrial dysfunction at the onset of human lactation.

The Journal of clinical investigation·2026

Lactylation-dependent DDX18 nucleolar escape regulates CD44 mRNA stability to drive fibrotic progression in kidney injury.

The Journal of clinical investigation·2026

Metabolic stress-activated endothelial STING rewires the sinusoidal immune niche in MASLD.

The Journal of clinical investigation·2026

METTL1-mediated m7G modification of valine tRNAs drives metabolic adaptation in pancreatic ductal adenocarcinoma.

The Journal of clinical investigation·2026

Targeting the E3 ubiquitin ligase RNF10 ameliorates metabolic dysfunction-associated steatohepatitis in mice.

The Journal of clinical investigation·2026

Local High-Protein, Plant-Based Ready-to-Use Therapeutic Food Enhances Recovery from Malnutrition in Rats.

Current developments in nutrition·2026

Nicotinamide Adenine Dinucleotide Augmentation in Diabetic Kidney Disease: Randomized Trial Study Protocol.

Kidney international reports·2026

Gut Microbiota and Ischemic Stroke: From Pre-Stroke Dysbiosis and Acute-Phase Changes to Therapeutic Applications.

Brain and behavior·2026

Rethinking obesity management targets: Findings from an international MoSCoW prioritization workshop.

Obesity pillars·2026

Qing-Re-Qu-Shi formula improves clinical outcomes and is accompanied by gut microbiota and microbial metabolite remodeling in adults with moderate atopic dermatitis: a randomized placebo-controlled multi-omics trial.

Frontiers in medicine·2026

Betaine as a regulator of metabolism, epigenetics, and cellular osmoprotection: therapeutic implications in cardiometabolic and renal diseases.

Frontiers in pharmacology·2026

Related Experiment Videos

Insulin resistance and cardiovascular disease

Related Concept Videos

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience.

Diabetes and dyslipidemia.

HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia.

Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance.

Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance.

Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus.

Tumor NLRP3 Amplification Promotes Immunotherapy Resistance by Inhibiting STAT1 Signaling and MHC Class I Expression.

Insulin resistance is associated with mammary mitochondrial dysfunction at the onset of human lactation.

Lactylation-dependent DDX18 nucleolar escape regulates CD44 mRNA stability to drive fibrotic progression in kidney injury.

Metabolic stress-activated endothelial STING rewires the sinusoidal immune niche in MASLD.

METTL1-mediated m7G modification of valine tRNAs drives metabolic adaptation in pancreatic ductal adenocarcinoma.

Targeting the E3 ubiquitin ligase RNF10 ameliorates metabolic dysfunction-associated steatohepatitis in mice.

Local High-Protein, Plant-Based Ready-to-Use Therapeutic Food Enhances Recovery from Malnutrition in Rats.

Nicotinamide Adenine Dinucleotide Augmentation in Diabetic Kidney Disease: Randomized Trial Study Protocol.

Gut Microbiota and Ischemic Stroke: From Pre-Stroke Dysbiosis and Acute-Phase Changes to Therapeutic Applications.

Rethinking obesity management targets: Findings from an international MoSCoW prioritization workshop.

Qing-Re-Qu-Shi formula improves clinical outcomes and is accompanied by gut microbiota and microbial metabolite remodeling in adults with moderate atopic dermatitis: a randomized placebo-controlled multi-omics trial.

Betaine as a regulator of metabolism, epigenetics, and cellular osmoprotection: therapeutic implications in cardiometabolic and renal diseases.

Related Experiment Videos

Insulin resistance and cardiovascular disease

Related Concept Videos

Related Articles